XML 20 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Interim Condensed Consolidated Statements Of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Total Stockholders' Equity - Dolby Laboratories, Inc.
Controlling Interest
Class A Common Stock [Member]
Common Stock
Class A Common Stock [Member]
Additional Paid-In Capital
Beginning balance (in shares) at Sep. 27, 2019   99,000              
Beginning balance at Sep. 27, 2019 $ 2,313,030   $ 0 $ 2,327,877 $ (20,625) $ 2,307,351 $ 5,679    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 204,643     204,534   204,534 109    
Other comprehensive income/(loss), net of tax 3,529       3,504 3,504 25    
Distributions to controlling interest (283)           (283)    
Stock-based compensation expense 64,850   64,850     64,850      
Shares repurchased (in shares)   (2,000)              
Repurchase of common stock (128,753)   (111,168) (17,583)   (128,753)      
Cash dividends declared and paid on common stock (66,439)     (66,439)   (66,439)      
Common stock issued under employee stock plans (in shares)               2,000  
Common stock issued under employee stock plans 68,289   68,287     68,289      
Tax withholdings on vesting of restricted stock (in shares)               0  
Tax withholdings on vesting of restricted stock (21,969)         (21,969)     $ (21,969)
Ending balance (in shares) at Jun. 26, 2020   99,000              
Ending balance at Jun. 26, 2020 2,436,897   0 2,448,389 (17,121) 2,431,367 5,530    
Beginning balance (in shares) at Mar. 27, 2020   99,000              
Beginning balance at Mar. 27, 2020 2,369,277   0 2,395,575 (31,615) 2,364,059 5,218    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 67,378     67,285   67,285 93    
Other comprehensive income/(loss), net of tax 14,713       14,494 14,494 219    
Stock-based compensation expense 21,285   21,285     21,285      
Shares repurchased (in shares)   (1,000)              
Repurchase of common stock (27,081)   (34,712) 7,632   (27,081)      
Cash dividends declared and paid on common stock (22,103)     (22,103)   (22,103)      
Common stock issued under employee stock plans (in shares)               1,000  
Common stock issued under employee stock plans 14,303   14,302     14,303      
Tax withholdings on vesting of restricted stock (in shares)               0  
Tax withholdings on vesting of restricted stock (875)         (875) 0   (875)
Ending balance (in shares) at Jun. 26, 2020   99,000              
Ending balance at Jun. 26, 2020 2,436,897   0 2,448,389 (17,121) 2,431,367 5,530    
Beginning balance (in shares) at Sep. 25, 2020   99,000              
Beginning balance at Sep. 25, 2020 2,438,405   0 2,443,138 (10,594) 2,432,643 5,762    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 273,595     266,036   266,036 7,559    
Other comprehensive income/(loss), net of tax 5,902       5,562 5,562 340    
Distributions to controlling interest (7,362)           (7,362)    
Stock-based compensation expense $ 75,562   75,562     75,562      
Shares repurchased (in shares) (1,611,650) (2,000)              
Repurchase of common stock $ (149,764)   (133,918) (15,844)   (149,764)      
Cash dividends declared and paid on common stock (66,883)     (66,883)   (66,883)      
Common stock issued under employee stock plans 89,148 $ 3 89,145     89,148      
Tax withholdings on vesting of restricted stock (30,789)         (30,789)     (30,789)
Ending balance (in shares) at Jun. 25, 2021   100,000              
Ending balance at Jun. 25, 2021 2,627,814   0 2,626,447 (5,032) 2,621,515 6,299    
Beginning balance (in shares) at Mar. 26, 2021   100,000              
Beginning balance at Mar. 26, 2021 2,594,220   0 2,591,870 (4,039) 2,587,931 6,289    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 54,560     54,621   54,621 (61)    
Other comprehensive income/(loss), net of tax (922)       (993) (993) 71    
Stock-based compensation expense 24,836   24,836     24,836      
Shares repurchased (in shares)   (1,000)              
Repurchase of common stock (38,989)   (41,253) 2,265   (38,989)      
Cash dividends declared and paid on common stock (22,309)     (22,309)   (22,309)      
Common stock issued under employee stock plans 17,991 $ 1 17,990     17,991      
Tax withholdings on vesting of restricted stock (in shares)               0  
Tax withholdings on vesting of restricted stock (1,573)       0 (1,573) 0   $ (1,573)
Ending balance (in shares) at Jun. 25, 2021   100,000              
Ending balance at Jun. 25, 2021 $ 2,627,814   $ 0 $ 2,626,447 $ (5,032) $ 2,621,515 $ 6,299